Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Scalp Psoriasis: later-stage trial registry
A small indexed set (3 trials) with no open enrollment listed right now.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · none currently recruiting · #5,209 of 28,707 conditions by registered trial count
Scalp Psoriasis: 3 US clinical trials tracked, none currently recruiting.
Scalp Psoriasis is the subject of 3 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 2 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Dermatology Consulting Services, P, running 1 of these trials.
Enrollment posture brief
Registry condition scalp-psoriasis
OPEN 0 | RECR 0% | LATE 2 | EARLY 1 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)
Scalp Psoriasis has no open enrollment in this registry pull (3 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Scalp Psoriasis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Scalp Psoriasis is recruiting below its size-band peers.
0 of 3 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Indexed trials (enrollment closed)
3 total, page 1 of 1
Efficacy and Safety of Tildrakizumab in the Treatment of Scalp Psoriasis
Sun Pharmaceutical Industries Limited
NCT03897088
A Demonstration of the Hair and Scalp Benefits of Duobrii in Scalp Psoriasis
Dermatology Consulting Services, P
NCT05872256
Safety Study in Patients With Scalp Psoriasis Suppression Following Maximal Use Treatment With Topical Product
Sun Pharmaceutical Industries
NCT02933502
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
| Phase 3 | 1 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Scalp Psoriasis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Scalp Psoriasis trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Scalp Psoriasis page
3 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- No Scalp Psoriasis trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Dermatology Consulting Services, P sponsors the most Scalp Psoriasis trials on record, review their full trial history before evaluating a specific study. See Dermatology Consulting Services, P's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Scalp Psoriasis condition card totals 3 registered trials; most-linked intervention PART 2: Double-blind Active Treatment Extension; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.